EMA Reveals 2013 Targets for New Trial Data Transparency Policies
The European Medicines Agency (EMA) has laid out a timeline for developing new policies to increase access to clinical trial data.
The agency expects to compile the proposed policies into a document by June 30, and release it for consultation until Sept. 30. A final policy document should be ready for publication by Nov. 30 and would take effect Jan. 1, 2014.
The groups are expected to convene between January and February and report their findings to the agency by April 30.
A one-of-a-kind newsletter, Clinical Trials Advisor offers readers practical advice on maximizing your clinical investments, updates on the latest regulatory and international news, reporting and training applicable to clinical trials and more.
Make your New Year’s resolution to learn two new industry facts each month, and we’ll help you keep that resolution when you get a subscription to Clinical Trials Advisor.